07:00 , Jun 11, 2001 |  BC Week In Review  |  Company News

BruCells S.A./N.V., Genzyme Molecular deal

BruCells granted GZMO an exclusive license to its technology for the fusion of dendritic and tumor cells. GZMO will sponsor a two-year research program at BruCells on the technology, which will be used to develop...
07:00 , Jun 4, 2001 |  BC Extra  |  Company News

GZMO, BruCells in licensing deal

BruCells (Brussels, Belgium) granted Genzyme Molecular Oncology (GZMO) an exclusive license to its technology for the fusion of dendritic and tumor cells. GZMO also will sponsor a two-year research program at BruCells for the fusion...